CD8A and neoplasm: In turn, this CD45RA−CCR7− Treg subset suppresses CD8+ T-cell anti-tumor function via IL-10 secretion and cell–cell contact mechanisms, and, in doing so, contribute to the immunosuppression and GC progression.